clearpointneuro.com (CLPT) Short-Term Debt to Capital

ClearPoint Neuro Inc. - graphic logo of issuer CLPT

The market trend for ClearPoint Neuro, Inc. (CLPT) shown on this price chart, where the metric stands at 0.14, is supported by stable demand driven by aging demographics and medical automation. Operations across clinics in Europe and America ensure business security, neutralizing political disputes. A flawless reputation and the superior precision of instruments for delicate brain interventions underpin this success.

ClearPoint Neuro, Inc. - CLPT Short-Term Debt to Equity Ratio (period 07/04/2022 - 10/28/2026)
Brand item of ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. (CLPT) specializes in the high-precision manufacture of neurosurgical navigation systems with a minimal environmental footprint. The debt_short_eq_co metric measures the proportion of liabilities maturing within one year relative to equity, determining current financial stability. It is critical for the investor to balance the protection of assets from degradation against the risk of underinvesting in electronics development. Analyzing the history of short-term debt to equity allows for the real-time tracking of the credit load between quarterly reports.

Competitors of ClearPoint Neuro, Inc.

BSX - Short-Term Debt to Equity|Current Liabilities to Equity Edwards Lifesciences Inc. (EW)|RMD: Short-Term Debt to Capital|Current Liabilities to Capital insulet.com PODD|ZBH: Short-Term Debt to Capital|COO - Short-Term Debt to Equity Ratio|Align Technology Inc - Short-Term Debt to Capital|NuVasive (GMED) - Short-Term Debt to Capital Coefficient|TMDX (TransMedics Group Inc) - Short-Term Debt to Capital|Short-Term Debt to Capital ATEC|Short-Term Debt to Equity Artivion (AORT)|Short-Term Debt to Equity Enovis Corp (ENOV)|Short-Term Debt to Capital IART|ESTA - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio Beta Bionics Inc|IRMD - Current Liabilities to Equity|Short-Term Debt to Capital EMBC|Tandem Diabetes Care Inc (TNDM) - Current Liabilities to Capital|Short-Term Debt to Capital Axogen Corp (AXGN)|Short-Term Debt to Capital Ratio SI-BONE Medical (SIBN)|Orthofix Medical Inc. (OFIX) - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital BVS (bioventus.com)|OrthoPediatrics - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Treace Medical Concepts Inc TMCI|SRTA (Strata Critical Medical Corp) - Short-Term Debt to Capital|CARL - Current Liabilities to Capital|Short-Term Debt to Capital RxSight, Inc.|stereotaxis.com (STXS) - Short-Term Debt to Capital Ratio|STIM: Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Sight Sciences Inc.|Short-Term Debt to Capital OBIO (Orchestra BioMed)|Short-Term Debt to Equity Ratio anikatherapeutics.com (ANIK)|Short-Term Debt to Capital NSPR (InspireMD, Inc.)|Jin Medical International Ltd. - Short-Term Debt to Capital|VANI - Short-Term Debt to Equity|Xtant Medical Holdings (XTNT) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio NeuroOne Corp NMTC|Modular Medical, Inc. (MODD) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital MYO (Myomo, Inc.)|Current Liabilities to Capital COCH|VVOS: Short-Term Debt to Equity|Short-Term Indebtedness to Equity enVVeno Medical Corporation NVNO|Short-Term Debt to Equity Ratio SINT (Sintx Technologies, Inc.)|Short-Term Debt to Capital Tenon Medical Inc TNON|Short-Term Debt to Capital LFWD (ReWalk Robotics Ltd.)|AMIX: Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity INVO Fertility (IVF)|BBLG (Bone Biologics Corp.) - Current Liabilities to Equity|Short-Term Debt to Equity AXNX|Short-Term Debt to Equity Ratio Biolase Inc.|Dynatronics Corporation - Short-Term Debt to Capital|Current Liabilities to Capital FNA (paragon28.com)|INVO - Short-Term Debt to Equity